Streetbeat News

Equity Actions

CAR

COIN

EMR

META

MSFT

OXY

TGT

TJX

TSEM

WBA

Elon Musk's X is accused of slowing traffic to sites criticized by him, including Instagram, owned by Meta Platforms Inc. Coinbase Global Inc has received federal approval for new futures offering. Tower Semiconductor Ltd's deal with Intel Corp has been terminated due to US-China tensions. Occidental Petroleum Corp is set to acquire Carbon Engineering Ltd for $1.1 billion. Emerson Electric Co is acquiring Flexim. Target Corp, TJX Companies Inc, and JD.com Inc have reported their Q2 earnings. Microsoft Corp's Game Pass is shaping the $60B gaming industry. Avis Budget Group Inc has been fined $275K for refusing to rent vehicles to customers without credit cards. Walgreens Boots Alliance Inc is facing a reopened lawsuit accusing it of Medicaid fraud.

Portfolio Pulse from Vandana Singh

August 16, 2023 | 2:01 pm

PSX

Phillips 66 (PSX) is being watched closely after Elliott Management disclosed a small stake in the company in its 13F filing. The company was highlighted as a potential target for activist investors by an event-driven analyst.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 1:53 pm

CVAC

Curevac shares are experiencing an upward trend, with active trading in January $15 calls.

Portfolio Pulse from Charles Gross

August 16, 2023 | 1:51 pm

CRKN

Crown Electrokinetics (CRKN) shares are trading lower by 9.6% after the company effected a 1-for-60 reverse stock split. The split was approved by the company's Board of Directors and stockholders on August 11. The reverse stock split impacts all stockholders without changing their proportional ownership in the company's common stock.

Portfolio Pulse from Henry Khederian

August 16, 2023 | 1:44 pm

ASML

SSNLF

TSM

Samsung Electronics has reportedly sold over half of its stake in ASML Holding during Q2 2021, reducing its stake from 1.6% to 0.7%. The sale, which fetched Samsung approximately $2.2 billion, is part of the company's strategy to bolster its semiconductor manufacturing division. The funds may be used to expand Samsung's chip manufacturing facilities.

Portfolio Pulse from Anusuya Lahiri

August 16, 2023 | 1:39 pm

VFC

Traders are circulating activist insight suggesting that a big activist is eyeing V.F. Corp, with Third Point Capital being mentioned.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 1:38 pm

INVZ

Innoviz Technologies Ltd. (NASDAQ:INVZ) has issued an open letter to its shareholders following its recently-completed underwritten public offering of ordinary shares. The letter highlights the company's strong operational execution and recent customer wins. Innoviz is currently participating in over five active RFQ sourcing processes with major automotive OEMs. The company believes it is in a once-in-a-lifetime market share capture window for the automotive LiDAR industry and that the additional cash from the offering will increase its chances of securing further customer wins.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 1:31 pm

HCANF

Halo Collective Inc. reported a 48.1% YoY decline in Q2 2023 revenue, amounting to $3.57 million. The company attributed the dip to an oversupply issue in Oregon and California, leading to lower prices. Additionally, Halo Collective has delisted its securities from the CBOE Exchange. Despite the revenue decline, the company saw a decrease in net loss and operating expenditures compared to Q2 2022. The company's shares closed 12.5% lower at $0.018 per share.

Portfolio Pulse from Nina Zdinjak

August 16, 2023 | 1:09 pm

HSDT

Helius Medical Technologies, Inc. (NASDAQ:HSDT) has announced a 1-for-50 reverse split of its Class A common stock, effective at 5:00 pm Eastern time today. The reverse split will reduce the number of shares of common stock outstanding and issuable upon the conversion of the Company's outstanding stock options and warrants in proportion to the ratio of the reverse split. The number of authorized shares of the Company's common stock will remain at 150 million, while the number of outstanding shares will be reduced from approximately 28.30 million to approximately 0.57 million.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 1:06 pm

WINT

Windtree Therapeutics, Inc. (NASDAQ:WINT) is developing istaroxime, a treatment for acute heart failure and cardiogenic shock, and is advancing to the next stage of development after three successful phase 2 trials. The company is also developing a next-generation drug platform based on SERCA2a activators. Windtree recently raised $12.4 million in a public stock offering and received a patent allowance from the USPTO for its dual mechanism SERCA2a activators. The company's Q1 2023 R&D expenses were $1.5 million, down from $5.3 million in Q1 2022.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 1:05 pm